港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

晶泰控股

10.550

-0.070-0.66%

成交量：1.79億

成交額：18.81億

市值：453.97億

市盈率：-12.25

高：10.780

開：10.780

低：10.300

收：10.620

52周最高：13.420

52周最低：3.050

股本：43.03億

香港流通股本：43.03億

量比：1.34

換手率：4.16%

股息：- -

股息率：- -

每股收益(LYR):-0.861

淨資產收益率：-3.61%

總資產收益率：-3.47%

市淨率：5.92

市盈率(LYR):-12.25

市銷率: 60.85

資料載入中...

總覽公司新聞公告

創新藥中場覆盤：泡沫擠壓後的新起點

Ofweek维科网

晶泰控股(2228.HK)：AI+人工智能自主實驗平臺驅動藥物及材料研發商業化加速

晶泰控股AI藥物發現合作達成重要里程碑：Pharmaengine新型Prmt5抑制劑Pep08獲得臨牀試驗批准

晶泰控股等在上海新設生物科技公司

每日賣空追蹤 | 晶泰控股 09月08日賣空量成交591.9萬股，賣空比例為3.63%

晶泰科技(02228)助力智擎生技新一代“合成致死”新藥獲臨牀實驗審批 AI製藥再迎里程碑

醫藥生物行業跟蹤週報：政策支持與技術迸發疊加看好腦機接口產業鏈發展建議關注誠益通、三博腦科等

異動解讀 | AI藥物研發龍頭晶泰控股盤中大漲8.09%，南向資金連續7日增持

晶泰科技到廣藥集團調研交流，共商合作新機遇

白云山官微

晶泰控股完成配售2.86億股淨籌26.3億港元加速業務擴張與研發投入

格隆汇资讯

晶泰控股(02228.HK)完成配售合共2.859億股新股份

每日賣空追蹤 | 晶泰控股 09月04日賣空量成交314.2萬股，賣空比例為1.98%

晶泰控股盤中異動下午盤大幅下挫5.08%

醫藥行業細分龍頭+醫藥政策頻出，該公司有望再爆發！

每日賣空追蹤 | 晶泰控股 09月02日賣空量成交1132.8萬股，賣空比例為6.12%

晶泰控股09月02日主力大幅流出1.3億元散戶資金買入

晶泰控股等成立新公司，含AI及機器人業務

晶泰控股：業績大幅提升 AI藥物研發進入新階段

每日賣空追蹤 | 晶泰控股 09月01日賣空量成交1657.1萬股，賣空比例為4.08%

港股異動 | 晶泰控股(02228.HK)再漲超8% 集團首次實現半年盈利高溢價鉅額配股仍獲市場資金熱捧

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02228/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02228","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":10.55,"timestamp":1758269290001,"preClose":10.62,"halted":0,"volume":179058834,"delay":0,"floatShares":4303000000,"shares":4303000000,"eps":-0.8613210808457035,"marketStatus":"未開盤","change":-0.07,"latestTime":"09-19 16:08:10","open":10.78,"high":10.78,"low":10.3,"amount":1881301486,"amplitude":0.045198,"askPrice":10.55,"askSize":1624000,"bidPrice":10.45,"bidSize":32758000,"shortable":3,"etf":0,"ttmEps":-0.05203179770300848,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1758504600000},"marketStatusCode":0,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":10.62,"openAndCloseTimeList":[[1758245400000,1758254400000],[1758258000000,1758268800000]],"volumeRatio":1.3388663543319708,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","floatShares":4303000000,"roa":"-3.47%","roe":"-3.61%","lyrEps":-0.861321,"volumeRatio":1.3388663543319708,"shares":4303000000,"dividePrice":0,"high":10.78,"amplitude":0.045198,"preClose":10.62,"low":10.3,"week52Low":3.05,"pbRate":"5.92","psRate":"60.85","week52High":13.42,"institutionHeld":0,"latestPrice":10.55,"committee":0.905532,"eps":-0.8613210808457035,"divideRate":0,"volume":179058834,"delay":0,"ttmEps":-0.05203179770300848,"open":10.78,"prevYearClose":5.98,"prevWeekClose":10.22,"prevMonthClose":10.31,"prevQuarterClose":5.81,"fiveDayClose":10.22,"twentyDayClose":10.17,"sixtyDayClose":5.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02228\",params:#limit:5,,,undefined,":[{"date":"2025-08-27","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756258200000,"name":null,"time":"","dateTimestamp":1756224000000,"actualEps":null},{"date":"2025-03-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02228\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02228\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1747065600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02228\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02228","date":"2025-09-19","current":-210.969495,"percent":0.009524,"low":-214.244134,"twenty":-12.227129,"median":-9.510018,"eighty":-7.835319,"high":-4.071689,"avg":-20.00392,"sd":42.944078,"marketCap":45395824578},"quantilePoints":[{"date":"2024-06-14","current":-8.922014,"twenty":-9.439723,"median":-9.245582,"eighty":-9.051441,"marketCap":18396572909},{"date":"2024-06-21","current":-8.857946,"twenty":-8.9092,"median":-8.775161,"eighty":-8.737522,"marketCap":18226234271},{"date":"2024-06-28","current":-8.745676,"twenty":-8.918198,"median":-8.816527,"eighty":-8.750223,"marketCap":17987760178},{"date":"2024-07-05","current":-8.747576,"twenty":-8.902934,"median":-8.771787,"eighty":-8.744343,"marketCap":17987760178},{"date":"2024-07-12","current":-9.049063,"twenty":-8.902934,"median":-8.775161,"eighty":-8.741587,"marketCap":18635047002},{"date":"2024-07-19","current":-9.247407,"twenty":-9.172529,"median":-8.857489,"eighty":-8.744343,"marketCap":19043859733},{"date":"2024-07-26","current":-9.575773,"twenty":-9.510189,"median":-8.892407,"eighty":-8.745676,"marketCap":19793349741},{"date":"2024-08-02","current":-9.235042,"twenty":-9.509847,"median":-8.912474,"eighty":-8.745676,"marketCap":19077927461},{"date":"2024-08-09","current":-9.468775,"twenty":-9.510189,"median":-8.974725,"eighty":-8.747576,"marketCap":19691146558},{"date":"2024-08-16","current":-10.464009,"twenty":-9.56947,"median":-9.142341,"eighty":-8.760904,"marketCap":21769277942},{"date":"2024-08-23","current":-10.517808,"twenty":-9.632925,"median":-9.235042,"eighty":-8.768412,"marketCap":21973684308},{"date":"2024-08-30","current":-10.371399,"twenty":-10.303269,"median":-9.325095,"eighty":-8.775161,"marketCap":28923500740},{"date":"2024-09-06","current":-18.461728,"twenty":-10.496901,"median":-9.468775,"eighty":-8.776023,"marketCap":51510404146},{"date":"2024-09-13","current":-17.236995,"twenty":-10.891661,"median":-9.521964,"eighty":-8.857032,"marketCap":47967360474},{"date":"2024-09-20","current":-16.063353,"twenty":-11.51195,"median":-9.559061,"eighty":-8.857763,"marketCap":44969400445},{"date":"2024-09-27","current":-15.483466,"twenty":-14.686278,"median":-9.575773,"eighty":-8.860072,"marketCap":43606691340},{"date":"2024-10-04","current":-13.755671,"twenty":-14.947547,"median":-9.615329,"eighty":-8.879685,"marketCap":38564667654},{"date":"2024-10-10","current":-12.348216,"twenty":-14.780027,"median":-9.846626,"eighty":-8.896618,"marketCap":34408404886},{"date":"2024-10-18","current":-11.446606,"twenty":-14.586898,"median":-10.272952,"eighty":-8.910566,"marketCap":31717054404},{"date":"2024-10-25","current":-12.086709,"twenty":-14.247622,"median":-10.371399,"eighty":-8.935918,"marketCap":33488576240},{"date":"2024-11-01","current":-11.046421,"twenty":-13.547793,"median":-10.507354,"eighty":-8.963954,"marketCap":30626887121},{"date":"2024-11-08","current":-8.233542,"twenty":-13.084166,"median":-10.464009,"eighty":-8.959678,"marketCap":22655038860},{"date":"2024-11-15","current":-6.674421,"twenty":-12.818197,"median":-10.331022,"eighty":-8.873325,"marketCap":18226234271},{"date":"2024-11-22","current":-5.092957,"twenty":-12.605094,"median":-9.956054,"eighty":-8.775506,"marketCap":13899632864},{"date":"2024-11-29","current":-4.071689,"twenty":-12.362191,"median":-9.633447,"eighty":-8.746436,"marketCap":11106079200},{"date":"2024-12-06","current":-6.234627,"twenty":-12.309524,"median":-9.607633,"eighty":-8.729287,"marketCap":16965728349},{"date":"2024-12-13","current":-4.937116,"twenty":-12.241743,"median":-9.572622,"eighty":-8.309283,"marketCap":13422684678},{"date":"2024-12-20","current":-6.992956,"twenty":-12.176011,"median":-9.548971,"eighty":-7.374004,"marketCap":18907588823},{"date":"2024-12-27","current":-7.61626,"twenty":-12.099333,"median":-9.521964,"eighty":-6.992956,"marketCap":20576907476},{"date":"2025-01-03","current":-6.613619,"twenty":-12.089234,"median":-9.489311,"eighty":-6.978437,"marketCap":17885556995},{"date":"2025-01-10","current":-5.450117,"twenty":-12.058756,"median":-9.391379,"eighty":-6.644107,"marketCap":14683190599},{"date":"2025-01-17","current":-5.875315,"twenty":-12.04248,"median":-9.241225,"eighty":-6.25569,"marketCap":15841493338},{"date":"2025-01-24","current":-6.177753,"twenty":-11.949888,"median":-9.172529,"eighty":-6.11967,"marketCap":16761321984},{"date":"2025-01-28","current":-6.498305,"twenty":-11.921589,"median":-9.112153,"eighty":-6.130311,"marketCap":17715218357},{"date":"2025-02-07","current":-7.424154,"twenty":-11.872333,"median":-8.96938,"eighty":-6.148709,"marketCap":20134027017},{"date":"2025-02-14","current":-8.323374,"twenty":-11.760531,"median":-8.922014,"eighty":-6.178085,"marketCap":22518767950},{"date":"2025-02-21","current":-10.607329,"twenty":-11.720414,"median":-8.939394,"eighty":-6.187416,"marketCap":28855365285},{"date":"2025-02-28","current":-8.380735,"twenty":-11.643652,"median":-8.964036,"eighty":-6.222464,"marketCap":22723174315},{"date":"2025-03-07","current":-8.409794,"twenty":-11.556185,"median":-8.912474,"eighty":-6.239893,"marketCap":22893512953},{"date":"2025-03-14","current":-8.131514,"twenty":-11.5122,"median":-8.860603,"eighty":-6.269085,"marketCap":22144022946},{"date":"2025-03-21","current":-7.997044,"twenty":-11.440339,"median":-8.816527,"eighty":-6.340941,"marketCap":21769277942},{"date":"2025-03-28","current":-9.307254,"twenty":-11.391935,"median":-8.776023,"eighty":-6.503525,"marketCap":25284615976},{"date":"2025-04-03","current":-13.220486,"twenty":-11.563082,"median":-8.857032,"eighty":-6.524404,"marketCap":21465794803},{"date":"2025-04-11","current":-11.616184,"twenty":-11.563082,"median":-8.876505,"eighty":-6.613619,"marketCap":18692124688},{"date":"2025-04-17","current":-8.481901,"twenty":-11.535495,"median":-8.876505,"eighty":-6.644107,"marketCap":18290143512},{"date":"2025-04-25","current":-9.200975,"twenty":-11.479403,"median":-8.897671,"eighty":-6.665344,"marketCap":19857870099},{"date":"2025-05-02","current":-9.49742,"twenty":-11.434072,"median":-8.939394,"eighty":-6.691701,"marketCap":20541238098},{"date":"2025-05-09","current":-8.545306,"twenty":-11.391935,"median":-8.912474,"eighty":-6.740034,"marketCap":18611728453},{"date":"2025-05-16","current":-7.908546,"twenty":-11.248155,"median":-8.860603,"eighty":-6.84782,"marketCap":17365586807},{"date":"2025-05-23","current":-8.341266,"twenty":-11.042865,"median":-8.857489,"eighty":-6.934878,"marketCap":18370539747},{"date":"2025-05-30","current":-8.359272,"twenty":-11.017454,"median":-8.801107,"eighty":-7.008251,"marketCap":18491134100},{"date":"2025-06-06","current":-8.60989,"twenty":-10.956499,"median":-8.771787,"eighty":-7.088154,"marketCap":19094105864},{"date":"2025-06-13","current":-11.034423,"twenty":-11.017454,"median":-8.801107,"eighty":-7.190725,"marketCap":24480653624},{"date":"2025-06-20","current":-10.674849,"twenty":-11.017454,"median":-8.857489,"eighty":-7.306284,"marketCap":23636493154},{"date":"2025-06-27","current":-10.445897,"twenty":-10.956499,"median":-8.892407,"eighty":-7.344497,"marketCap":23194313860},{"date":"2025-07-04","current":-9.829906,"twenty":-10.891661,"median":-8.922014,"eighty":-7.419935,"marketCap":21827577862},{"date":"2025-07-11","current":-10.057272,"twenty":-10.877908,"median":-8.960404,"eighty":-7.424154,"marketCap":22309955273},{"date":"2025-07-18","current":-11.044472,"twenty":-10.891661,"median":-8.991768,"eighty":-7.446553,"marketCap":24480653624},{"date":"2025-07-25","current":-11.600754,"twenty":-10.891661,"median":-9.041584,"eighty":-7.524651,"marketCap":25807191505},{"date":"2025-08-01","current":-10.363772,"twenty":-11.018326,"median":-9.112153,"eighty":-7.542967,"marketCap":22912927037},{"date":"2025-08-08","current":-12.886171,"twenty":-11.034423,"median":-9.184965,"eighty":-7.546272,"marketCap":28560882520},{"date":"2025-08-15","current":-16.789867,"twenty":-11.214642,"median":-9.213525,"eighty":-7.606542,"marketCap":37157266289},{"date":"2025-08-22","current":-18.517848,"twenty":-11.446606,"median":-9.246727,"eighty":-7.614904,"marketCap":40852907909},{"date":"2025-08-29","current":-192.489316,"twenty":-11.600754,"median":-9.307254,"eighty":-7.61626,"marketCap":41415288155},{"date":"2025-09-05","current":-213.80174,"twenty":-11.767021,"median":-9.420728,"eighty":-7.685893,"marketCap":45955204407},{"date":"2025-09-12","current":-204.225419,"twenty":-12.040158,"median":-9.491689,"eighty":-7.778357,"marketCap":43975860397},{"date":"2025-09-19","current":-210.969495,"twenty":-12.227129,"median":-9.510018,"eighty":-7.835319,"marketCap":45395824578}],"updateTime":1758478798794},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02228\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566678767","title":"創新藥中場覆盤：泡沫擠壓後的新起點","url":"https://stock-news.laohu8.com/highlight/detail?id=2566678767","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566678767?lang=zh_tw&edition=fundamental","pubTime":"2025-09-10 15:08","pubTimestamp":1757488085,"startTime":"0","endTime":"0","summary":"在刚刚落幕的 WCLC，中国创新药企集中展示最新成果。随着二级市场回暖、业绩高增长与出海加速，泡沫挤压之后的创新药，正以临床价值和商业成果为双翼，迎来一个更理性、更健康、也更值得期待的新起点。参考资料1.wind，万联证券研究所2.各公司官网原文标题 : 创新药中场复盘：泡沫挤压后的新起点","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509101509049784db77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509101509049784db77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","01276","01530","06978","01177","02269","03692","09926","01093","01801","02162","BK1574","02157","09995","BK1161","02228","BK1141","06160","BK1617"],"gpt_icon":1},{"id":"2566048926","title":"晶泰控股(2228.HK)：AI+人工智能自主實驗平臺驅動藥物及材料研發 商業化加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2566048926","media":"招商证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566048926?lang=zh_tw&edition=fundamental","pubTime":"2025-09-10 00:00","pubTimestamp":1757433600,"startTime":"0","endTime":"0","summary":"晶泰以量子物理为基础，融合人工智能与机器人自动化技术，早期即着手数据积累，构建多模态AI 模型体系，覆盖药物发现核心环节。AI 制药商业化逐步落地。3）领先的机器人实验室：晶泰拥有200+研发机器人工站，5000m2+自有自动化实验室，以及先进的AI Agent 系统，为物质研发提供全链路保障。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091021013295215376&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091021013295215376&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1617","BK1141"],"gpt_icon":1},{"id":"1162905053","title":"晶泰控股AI藥物發現合作達成重要里程碑：Pharmaengine新型Prmt5抑制劑Pep08獲得臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1162905053","media":"美股速递","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162905053?lang=zh_tw&edition=fundamental","pubTime":"2025-09-09 20:41","pubTimestamp":1757421677,"startTime":"0","endTime":"0","summary":"晶泰控股AI药物发现合作项目取得重要进展，合作伙伴Pharmaengine开发的新型Prmt5抑制剂Pep08成功获得临床试验批准，标志着该合作项目达成重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228","BK1617","BK1141"],"gpt_icon":0},{"id":"2566651673","title":"晶泰控股等在上海新設生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2566651673","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566651673?lang=zh_tw&edition=fundamental","pubTime":"2025-09-09 09:24","pubTimestamp":1757381083,"startTime":"0","endTime":"0","summary":"人民财讯9月9日电，企查查APP显示，近日，艾玮泰（上海）生物科技有限公司成立，注册资本1000万元，经营范围包含：药物检测仪器销售；制药专用设备制造；医用包装材料制造；包装材料及制品销售等。企查查股权穿透显示，该公司由晶泰控股等共同持股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509093508383869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1617","BK1141","02228"],"gpt_icon":0},{"id":"2565089502","title":"每日賣空追蹤 | 晶泰控股 09月08日賣空量成交591.9萬股，賣空比例為3.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565089502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565089502?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 16:30","pubTimestamp":1757320229,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间09月08日，涨0.28%，卖空量成交591.9万股%，较上一交易日减少4.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908173916a71634c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908173916a71634c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"2565576164","title":"晶泰科技(02228)助力智擎生技新一代“合成致死”新藥獲臨牀實驗審批 AI製藥再迎里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2565576164","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565576164?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 09:20","pubTimestamp":1757294413,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰科技今日宣布，由其助力智擎生技制药发现的新一代PRMT5抑制剂PEP08已达成重要临床研发里程碑。基于此进展，晶泰科技确认获得该项目的里程碑付款。PEP08顺利获得两地监管机构的临床试验许可并达成里程碑付款，是晶泰科技与智擎生技合作取得的重要阶段性成果，再一次验证了晶泰科技平台高效赋能药物创新的交付能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1141","01477","02228","BK1191","BK1617"],"gpt_icon":1},{"id":"2565523226","title":"醫藥生物行業跟蹤週報：政策支持與技術迸發疊加 看好腦機接口產業鏈發展 建議關注誠益通、三博腦科等","url":"https://stock-news.laohu8.com/highlight/detail?id=2565523226","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565523226?lang=zh_tw&edition=fundamental","pubTime":"2025-09-07 00:00","pubTimestamp":1757174400,"startTime":"0","endTime":"0","summary":"政策支持明确，技术突破显著，应用场景清晰，看好脑机接口产业链发展：脑机接口技术当前已经成为全球各国科技竞争的战略高地之一。2025 年我国成功开展首例侵入式脑机接口的前瞻性临床试验，诚益通等企业在侵入式电极方面也有所布局；翔宇医疗已开发11 款非侵入式脑机接口产品等。建议关注国内在脑机接口领域布局企业如：诚益通、三博脑科、翔宇医疗、创新医疗等。博瑞医药自主研发的1 类创新药BGM1812 注射液1 期临床申请已获受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250907194121a4b93020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250907194121a4b93020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02359","01276","01530","BK1583","02228","BK1593"],"gpt_icon":1},{"id":"1199659528","title":"異動解讀 | AI藥物研發龍頭晶泰控股盤中大漲8.09%，南向資金連續7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1199659528","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199659528?lang=zh_tw&edition=fundamental","pubTime":"2025-09-05 11:22","pubTimestamp":1757042568,"startTime":"0","endTime":"0","summary":"周五盘中，港股生物医药板块AI药物研发龙头晶泰控股股价大涨8.09%，引起市场广泛关注。首先，晶泰控股上半年业绩亮眼。据报道，9月4日南向资金增持晶泰控股2806.30万股，这已经是连续第7个交易日增持。截至9月4日收盘，港股通共持有晶泰控股175088.99万股，占流通股43.59%。随着生物医药行业创新步伐加快，AI技术在药物研发中的应用日益广泛，晶泰控股有望继续受益于行业发展趋势，保持增长势头。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":1},{"id":"2564305853","title":"晶泰科技到廣藥集團調研交流，共商合作新機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2564305853","media":"白云山官微","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564305853?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 22:20","pubTimestamp":1756995600,"startTime":"0","endTime":"0","summary":"9月3日，晶泰科技联合创始人、首席执行官马健一行到访广药集团。陈杰辉对晶泰科技的分享表示感谢，并介绍了广药集团的业务板块、发展方向和科研创新情况。晶泰科技作为一家优秀的智能化、自动化驱动的药物研发科技公司，双方可进一步加强对接沟通和协商，围绕产业重点领域关键方向构建合作机制，开启互利共赢、赋能创新的合作新局面。广药集团将积极利用AI科技赋能创新研发，以新质生产力助力生物医药产业高质量发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-09-04/doc-infpkapc8400176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1617","02228","162414","BK1141"],"gpt_icon":1},{"id":"2564832072","title":"晶泰控股完成配售2.86億股  淨籌26.3億港元加速業務擴張與研發投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2564832072","media":"格隆汇资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564832072?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 17:35","pubTimestamp":1756978554,"startTime":"0","endTime":"0","summary":"格隆汇9月4日丨晶泰控股宣布，配售协议所载全部条件均获达成，配售于2025年9月4日完成。根据配售协议的条款及条件，配售代理已按配售价每股配售股份9.28港元向不少于六名承配人成功配售合共2.86亿股新股份，占紧随配售完成后公司经扩大已发行股本约6.64%。配售所得款项总额约为26.533亿港元，而配售产生的所得款项净额约为26.298亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509041736539512fa8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509041736539512fa8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2564320442","title":"晶泰控股(02228.HK)完成配售合共2.859億股新股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2564320442","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564320442?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 17:33","pubTimestamp":1756978430,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2564207633","title":"每日賣空追蹤 | 晶泰控股 09月04日賣空量成交314.2萬股，賣空比例為1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564207633","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564207633?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 16:30","pubTimestamp":1756974628,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间09月04日，跌5.18%，卖空量成交314.2万股%，较上一交易日减少58.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904172337a4b398ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904172337a4b398ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1617","BK1141"],"gpt_icon":0},{"id":"2564325152","title":"晶泰控股盤中異動 下午盤大幅下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564325152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564325152?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 14:27","pubTimestamp":1756967255,"startTime":"0","endTime":"0","summary":"2025年09月04日下午盘14时27分，晶泰控股股票出现异动，股价大幅下跌5.08%。晶泰控股股票所在的生物技术行业中，整体跌幅为5.83%。该信息摘要如下：晶泰控股盘中涨超8%，截至发稿，股价上涨7.37%，现报11.07港元，成交额19.87亿港元。晶泰控股近日发布中期业绩，收入5.17亿元人民币，同比增加403.83%；股东应占溢利8279.5万元，上年同期股东应占亏损12.37亿元，为集团首次实现半年盈利。此外，8月29日，晶泰控股宣布拟通过配售代理配售最多约2.86亿股配售股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509041427359512a025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509041427359512a025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":1},{"id":"2564331718","title":"醫藥行業細分龍頭+醫藥政策頻出，該公司有望再爆發！","url":"https://stock-news.laohu8.com/highlight/detail?id=2564331718","media":"巨丰投顾","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564331718?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 06:28","pubTimestamp":1756938494,"startTime":"0","endTime":"0","summary":"今天带来一只医药行业细分龙头，一起看看背后的起爆逻辑。下游是流通与终端应用，药品经线下医院、药店，以及线上电商平台等渠道，抵达终端消费者。医药行业未来发展趋势在创新药领域，随着老龄化加深及疾病谱改变，对创新药需求激增。像人福医药，连续6年将医药工业10%以上营收投入研发，2025年上半年6款1类新药获批临床，未来创新药有望持续突破，引领行业发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904062914a4b2704f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904062914a4b2704f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","01276","02196","BK1161","BK1515","02228","09939","BK1191","LU0359201612.USD","LU0359202008.SGD","LU1023057109.AUD","BK1574","LU2543165471.USD"],"gpt_icon":1},{"id":"2564803692","title":"每日賣空追蹤 | 晶泰控股 09月02日賣空量成交1132.8萬股，賣空比例為6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564803692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564803692?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 16:30","pubTimestamp":1756801828,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间09月02日，跌1.5%，卖空量成交1132.8万股%，较上一交易日减少67.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902172303a4af5fb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902172303a4af5fb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2564701248","title":"晶泰控股09月02日主力大幅流出1.3億元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2564701248","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564701248?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 16:15","pubTimestamp":1756800956,"startTime":"0","endTime":"0","summary":"09月02日, 晶泰控股股价跌1.50%，报收9.84元，成交金额18.4亿元，换手率4.61%，振幅6.11%，量比0.61。晶泰控股今日主力资金净流出1.3亿元，上一交易日主力净流入1.0亿元。该股近5个交易日下跌4.93%，主力资金累计净流出4763.5万元；近20日主力资金累计净流入5.2亿元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902170608a70b39e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902170608a70b39e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2564820406","title":"晶泰控股等成立新公司，含AI及機器人業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2564820406","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564820406?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 12:28","pubTimestamp":1756787287,"startTime":"0","endTime":"0","summary":"人民财讯9月2日电，企查查APP显示，近日，广州恒晶智创科技发展有限公司成立，注册资本6000万元，经营范围包含：人工智能应用软件开发；智能机器人的研发；智能机器人销售；生物化工产品技术研发等。企查查股权穿透显示，该公司由晶泰控股关联公司深圳晶泰科技有限公司等共同持股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902122807a4aecfbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902122807a4aecfbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2564387746","title":"晶泰控股：業績大幅提升 AI藥物研發進入新階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2564387746","media":"信达证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564387746?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 00:00","pubTimestamp":1756742400,"startTime":"0","endTime":"0","summary":"以“最强AI 大脑与机器人技术深度融合”为驱动，推动药物研发业务迈入新阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902165121a4af4a58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902165121a4af4a58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":1},{"id":"2564815797","title":"每日賣空追蹤 | 晶泰控股 09月01日賣空量成交1657.1萬股，賣空比例為4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564815797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564815797?lang=zh_tw&edition=fundamental","pubTime":"2025-09-01 16:30","pubTimestamp":1756715427,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间09月01日，跌3.1%，卖空量成交1657.1万股%，较上一交易日减少80.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901173417a7091f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901173417a7091f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2564980860","title":"港股異動 | 晶泰控股(02228.HK)再漲超8% 集團首次實現半年盈利 高溢價鉅額配股仍獲市場資金熱捧","url":"https://stock-news.laohu8.com/highlight/detail?id=2564980860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564980860?lang=zh_tw&edition=fundamental","pubTime":"2025-09-01 11:54","pubTimestamp":1756698883,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","02228","BK1617"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":191,"code":"91000000","status":"200"}]}}